Abxis Co., Ltd. (086890) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Abxis Co., Ltd. (086890:KRX), powered by AI.

Current Price
₩3,530
P/E Ratio
-13.5
Market Cap
143.9B
Sector
Common Stock
What is the Abxis Co., Ltd. stock price forecast?

Abxis Co., Ltd. is currently trading at ₩3,530. View real-time AI analysis on Alpha Lenz.

What is Abxis Co., Ltd. insider trading activity?

View the latest insider trading data for Abxis Co., Ltd. on Alpha Lenz.

What is Abxis Co., Ltd.'s P/E ratio?

Abxis Co., Ltd.'s P/E ratio is -13.5.

Abxis Co., Ltd.

KRX · 086890
₩3,530+150(+4.44%)Market closedKRX regular session 09:00–15:30 KST
Ask about Abxis Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Abxis Co., Ltd. trades at a P/E of -13.5 (undervalued) with modest ROE of -9.9%. 3Y revenue CAGR of 11.2% highlights clear growth momentum.

Ask for details

Company Overview

Abxis Co., Ltd. is a notable entity in the biotechnology and pharmaceuticals sector. Renowned for its innovative approach, the company specializes in the development, manufacturing, and marketing of biotechnological products and pharmaceuticals. Primarily focusing on the creation of therapeutic antibodies, Abxis Co., Ltd. plays a significant role in advancing medical treatments that target specific diseases with precision. The firm's contributions are particularly impactful in areas like oncology and immunology, where targeted therapies can significantly enhance patient outcomes. Situated within a competitive industry landscape, Abxis Co., Ltd.’s strategic partnerships and cutting-edge research initiatives underscore its commitment to addressing global health challenges. Through continuous innovation, Abxis Co., Ltd. not only strengthens its market presence but also aligns with the growing demand for advanced medical solutions, reinforcing its position as a key player in the biotech and pharmaceutical markets.

CEO유준수
SectorCommon Stock
IndustryCommon Stock
0

Company Statistics

FY 2025

Profile

₩143,935,545,260Market Cap
₩56,672,366,040Revenue
40.77MShares Out
0Employees

Margins

53.82%Gross
9.63%EBITDA
2.88%Operating
-21.47%Pre-Tax
-18.84%Net

Valuation

-13.48P/E
1.26P/B
2.54EV/Sales
27.61EV/EBITDA
-1603.99P/FCF

Growth (CAGR)

11.24%Rev 3Yr
17.22%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-6.69%ROA
-9.92%ROE
-3.14%ROIC

Financial Health

₩22,641,291,830Cash & Cash Equivalents
₩21,795,655,650Net Debt
38.82%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Abxis Co., Ltd. (ticker: 086890) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $143.9B.

The current price is ₩3,530 with a P/E ratio of -13.48x and P/B of 1.26x.

ROE is -9.92% and operating margin is 2.88%. Annual revenue is $56.7B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Abxis Co., Ltd. (086890) Stock Forecast 2026 ₩3,530 — Price, Financials & Analyst Targets | Alpha Lenz